Verheijden, Rik J. http://orcid.org/0000-0003-1966-1063
van Eijs, Mick J. M. http://orcid.org/0000-0002-9763-6704
May, Anne M.
van Wijk, Femke http://orcid.org/0000-0001-8343-1356
Suijkerbuijk, Karijn P. M. http://orcid.org/0000-0003-3604-5430
Article History
Received: 22 December 2022
Accepted: 18 April 2023
First Online: 12 May 2023
Competing interests
: K.P.M.S. has advisory relationships with Bristol Myers Squibb, Novartis, MSD, Pierre Fabre and AbbVie and received honoraria from Novartis, MSD and Roche. Research funding: BMS, Philips and TigaTx are All paid to the institution. F.v.W. has received advisory/speaker fees from Takeda and Johnson&Johnson, and has received research funding from BMS, Takeda, Sanofi, Pfizer, Galapagos and Leo Pharma. No potential conflicts of interest were disclosed by the other authors.